CRC has an immunosuppressive TME which stops the event of a good response to ICB therapies. There is Consequently an urgent should determine the methods reprogram this suppressive TME to be able to enhance immunotherapy efficacy. In the current study, we used CRISPR KO screens to discover genes that sensitize https://genef186vze9.shivawiki.com/user